Also good to see that the average revenue per product has increased threefold. Can't wait to see financials at the end of this year compared to last.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025